Japan Lifeline Publishes Transcript of FY2027 Q2 Financial Results Briefing

By Public Technologies
  • Japan Lifeline maintained its full-year outlook at its October 30, 2026, second-quarter results briefing for the fiscal year ending March 2027.
  • Attendees included Keisuke Suzuki, Tatsuya Murase, Takeyoshi Egawa, Takashi Ito and investor relations representative Fumiya Shinohara.
  • First-half revenue rose 7.1% to JPY 31.35 billion, supported by EP/Ablation and Neurovascular sales.
  • Operating profit fell 17.4% to JPY 5.47 billion as increased research spending, personnel costs and acquisition-related fees weighed.
  • Management targets approximately JPY 10 billion in US sales around 2032, using acquired Cross Vascular to accelerate market entry.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JLL - Japan Lifeline Co. Ltd. published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk